Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

Human Brain Project: what ethical questions are raised?

Published on: 09/07/2015 Reading time: 1 min
Christine Mitchell, Professeur à l’Université de Harvard
Retour à la recherche

During the Second Neurothics Network meeting, Christine Mitchell, professor at Harvard University and researcher in the "Human Brain Project," explain the mission of the project and some of the ethical questions it raises.

Understanding the human brain is one of the most important challenges of the 21st century. If we meet this challenge, we will better understand what makes us human, develop new treatments and construct informatics infrastructures on a world-wide scale.

The "Human Brain Project" is a European project that will receive 1.2 billion Euros over 10 years. It aims to better understand the human brain and its different pathologies, to simulate it and to map it.

One axe of the project is to centralize and make accessible all data available on the human brain, and thus medical information associated with different pathologies, thanks to information and communication technologies.

The collection of information concerning patients with neurodegenerative diseases and the evolution of the disease as a function of various factors, notably genetic, would allow clinicians to develop precision medicine by extrapolating the data to other patients.

Two categories of questions are raised by the project. The first is not limited to the neurosciences and concerns the collection medical information on patients in a source that is freely accessible to clinicians. This requires assuring the confidentiality of the collected data.

The second category of questions concerns what we learn from the neurosciences. In the near future, for example, it might be possible to predict and modify the behaviour of an individual by electrical stimulation, pharmacological agents or surgery. In the case of an incurable mental disease, this might be desirable but, in other cases, the use of such methods is debatable. Another subject of debate is the authorisation to improve cognitive function in healthy individuals.

"We are in the age of the neurosciences and, in the next decades, we will have much more information on the brain than we ever had. We are full of hopes concerning progress in the neurosciences, particularly for persons suffering from diseases of the brain," Christine Mitchell concluded.

Our news on the subject

L’IRM structurelle ne permet pas, à elle seule, de diagnostiquer la dépression
Structural MRI alone cannot diagnose depression
Can brain imaging reveal whether a person is affected by depression? This question has driven research for many years. Changes in brain structure have indeed been observed in patients with depression, suggesting that structural MRI might one day help...
03.12.2026 Research, science & health
Épilepsie temporale : une nouvelle stratégie pour corriger l’activité électrique anormale
Temporal Lobe Epilepsy: A New Strategy to Correct Abnormal Electrical Activity
Many patients suffer from epilepsy that cannot be controlled by current medications. Surgical removal of epileptogenic brain regions is effective in only about half of cases, and not all patients are eligible for the procedure. For these individuals...
03.06.2026 Research, science & health
Stimuler les mitochondries pour doper la mémoire à long terme
Stimulating Mitochondria to Boost Long-Term Memory
An international team led by Jaime de Juan-Sanz at the Paris Brain Institute has shown that slightly increasing the metabolic capacity of neurons can enhance long-term memory in both fruit flies and mice. The study, published in Nature Metabolism...
02.24.2026 Research, science & health
Traitements anti-Alzheimer
Anti-Alzheimer Treatments: A Long-Term Beneficial Effect on Symptoms
There is currently no cure for Alzheimer's disease. The treatments available in France—which are not reimbursed—are known as symptomatic treatments, meaning that they act on the consequences of the disease rather than its underlying cause. In 2018...
02.19.2026 Research, science & health
État de mal épileptique
Status Epilepticus: New Insights Gained from National Health Data
The most severe form of epilepsy, status epilepticus is a high-risk neurological emergency. Yet its epidemiology remains poorly understood, particularly in France. By analyzing data from the French National Health Insurance system, compiled within...
02.19.2026 Research, science & health
Sclérose en plaques : identification d’une nouvelle molécule favorisant la remyélinisation
Multiple Sclerosis: Identification of a Molecule that Promotes Repair of the Nervous System
A molecule previously studied in the context of sleep disorders and attention deficit hyperactivity disorder (ADHD) is now, for the first time, revealing its potential in experimental models of multiple sclerosis (MS): it protects neurons and...
01.27.2026 Research, science & health
See all our news